The keystone-pathogen hypothesis

Nature Reviews Microbiology

Volumn 10, Issue 10, 2012, Pages 717-725

  Hajishengallis, George ^a   Darveau, Richard P ^b   Curtis, Michael A ^c  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BIOFILM; CITROBACTER RODENTIUM; COLON CANCER; DIABETES MELLITUS; ENTERITIS; HUMAN; HYPOTHESIS; KEYSTONE PATHOGEN HYPOTHESIS; KLEBSIELLA PNEUMONIAE; MICROFLORA; NONHUMAN; OBESITY; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEUS MIRABILIS; REVIEW; RHEUMATOID ARTHRITIS; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA;

BACTERIA; COLONIC NEOPLASMS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METAGENOME; MICROBIAL INTERACTIONS; MODELS, BIOLOGICAL; PERIODONTITIS;

EID: 84867887781     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2873     Document Type: Review

References (86)

1. Paine R. T. A note on trophic complexity and community stability. Am. Nat. 103, 91-93 (1969).
2. Power, M. E. et al. Challenges in the quest for keystones. Bioscience 46, 609-620 (1996).
3. Estes, J. A. & Palmisano, J. F. Sea otters: their role in structuring nearshore communities. Science 185, 1058-1060 (1974).
4. Paine, R. T. Food web complexity and cpecies diversity. Am. Nat. 100, 65-75 (1966).
5. Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011).
6. Nell, S., Suerbaum, S. & Josenhans, C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nature Rev. Microbiol. 8, 564-577 (2010).
7. Littman, D. R. & Pamer, E. G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 10, 311-323 (2011).
8. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Rev. Immunol. 8, 411-420 (2008). (Pubitemid 351733416)
9. Darveau, R. P. Periodontitis: a polymicrobial disruption of host homeostasis. Nature Rev. Microbiol. 8, 481-490 (2010).
10. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
11. Stecher, B. et al. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5, 2177-2189 (2007). (Pubitemid 350035420)
12. Pihlstrom, B. L., Michalowicz, B. S. & Johnson, N. W. Periodontal diseases. Lancet 366, 1809-1820 (2005). (Pubitemid 41642647)
13. Genco, R. J. & Van Dyke, T. E. Prevention: reducing the risk of CVD in patients with periodontitis. Nature Rev. Cardiol. 7, 479-480 (2010).
14. Lundberg, K., Wegner, N., Yucel-Lindberg, T. & Venables, P. J. Periodontitis in RA-the citrullinated enolase connection. Nature Rev. Rheumatol. 6, 727-730 (2010).
15. Lalla, E. & Papapanou, P. N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nature Rev. Endocrinol. 7, 738-748 (2011).
16. Gaffen, S. L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817-828 (2008).
17. Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunol. 13, 465-473 (2012).
18. Moore, W. E. et al. Bacteriology of severe periodontitis in young adult humans. Infect. Immun. 38, 1137-1148 (1982). (Pubitemid 13206265)
19. Socransky, S. S. Microbiology of periodontal disease present status and future considerations. J. Periodontol. 48, 497-504 (1977). (Pubitemid 8194161)
20. Holt, S. C., Ebersole, J., Felton, J., Brunsvold, M. & Kornman, K. S. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239, 55-57 (1988). (Pubitemid 18029495)
21. Holt, S. C. & Ebersole, J. L. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 2000 38, 72-122 (2005). (Pubitemid 43034324)
22. Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C. & Kent, R. L. Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25, 134-144 (1998). (Pubitemid 128705944)
23. Hajishengallis, G. & Lambris, J. D. Microbial manipulation of receptor crosstalk in innate immunity. Nature Rev. Immunol. 11, 187-200 (2011).
24. Darveau, R. P. The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol. 28, 389-395 (2009).
25. Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497-506 (2011).
26. Wang, M. et al. Microbial hijacking of complement Toll-like receptor crosstalk. Sci. Signal. 3, ra11 (2010).
27. Liang, S. et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186, 869-877 (2011).
28. Darveau, R. P., Belton, C. M., Reife, R. A. & Lamont, R. J. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 66, 1660-1665 (1998). (Pubitemid 128471532)
29. Madianos, P. N., Papapanou, P. N. & Sandros, J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect. Immun. 65, 3983-3990 (1997). (Pubitemid 27422047)
30. Bainbridge, B. et al. Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect. Immun. 78, 4560-4569 (2010).
31. Frias-Lopez, J. & Duran-Pinedo, A. Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model. J. Bacteriol. 194, 2082-2095 (2012).
32. Hasturk, H. et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J. Immunol. 179, 7021-7029 (2007).
33. Page, R. C. et al. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis. Oral Microbiol. Immunol. 22, 162-168 (2007). (Pubitemid 46691092)
34. Kumar, P. S. et al. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J. Clin. Microbiol. 44, 3665-3673 (2006). (Pubitemid 46768783)
35. Doungudomdacha, S., Rawlinson, A. & Douglas, C. W. Enumeration of Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans in subgingival plaque samples by a quantitative- competitive PCR method. J. Med. Microbiol. 49, 861-874 (2000).
36. Chaves, E. S., Jeffcoat, M. K., Ryerson, C. C. & Snyder, B. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy. J. Clin. Periodontol. 27, 897-903 (2000).
37. Moore, W. E. et al. The microflora of periodontal sites showing active destructive progression. J. Clin. Periodontol. 18, 729-739 (1991).
38. Frank, D. N. & Pace, N. R. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol. 24, 4-10 (2008). (Pubitemid 350190890)
39. Chassaing, B. & Darfeuille-Michaud, A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728 (2011).
40. Garrett, W. S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007). (Pubitemid 47505255)
41. Garrett, W. S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292-300 (2010).
42. Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129 (2007). (Pubitemid 47209521)
43. Hoffmann, C. et al. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect. Immun. 77, 4668-4678 (2009).
44. Bry, L., Brigl, M. & Brenner, M. B. CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium. Infect. Immun. 74, 673-681 (2006). (Pubitemid 43023123)
45. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
46. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
47. Rogers, A. B. & Fox, J. G. Inflammation and Cancer I. Rodent models of infectious gastrointestinal and liver cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G361-G366 (2004). (Pubitemid 38250307)
48. Uronis, J. M. et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 4, e6026 (2009).
49. Azcarate-Peril, M. A., Sikes, M. & Bruno-Barcena, J. M. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver Physiol. 301, G401-G424 (2011).
50. Hope, M. E., Hold, G. L., Kain, R. & El-Omar, E. M. Sporadic colorectal cancer - role of the commensal microbiota. FEMS Microbiol. Lett. 244, 1-7 (2005). (Pubitemid 40261172)
51. Sears, C. L. & Pardoll, D. M. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis. 203, 306-311 (2011).
52. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Med. 15, 1016-1022 (2009).
53. Holton, J. Enterotoxigenic Bacteroides fragilis. Curr. Infect. Dis. Rep. 10, 99-104 (2008).
54. Sears, C. L. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22, 349-369 (2009).
55. Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev. Immunol. 7, 41-51 (2007). (Pubitemid 46020826)
56. Round, J. L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977 (2011).
57. Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008). (Pubitemid 351769307)
58. Wu, S., Morin, P. J., Maouyo, D. & Sears, C. L. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124, 392-400 (2003). (Pubitemid 36169256)
59. Kim, J. M. et al. Nuclear factor-κB activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin. Exp. Immunol. 130, 59-66 (2002).
60. Tjalsma, H., Boleij, A., Marchesi, J. R. & Dutilh, B. E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature Rev. Microbiol. 10, 575-582 (2012).
61. Toprak, N. U. et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12, 782-786 (2006).
62. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298 (2012).
63. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306 (2012).
64. Maddocks, O. D., Short, A. J., Donnenberg, M. S., Bader, S. & Harrison, D. J. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS ONE 4, e5517 (2009).
65. Martin, H. M. et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127, 80-93 (2004). (Pubitemid 38962277)
66. Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA 107, 11537-11542 (2010).
67. Walker, A. Say hello to our little friends. Nature Rev. Microbiol. 5, 572-573 (2007). (Pubitemid 47074112)
68. Strocchi, A., Furne, J., Ellis, C. & Levitt, M. D. Methanogens outcompete sulphate reducing bacteria for H2 in the human colon. Gut 35, 1098-1101 (1994). (Pubitemid 24244266)
69. Samuel, B. S. et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc. Natl Acad. Sci. USA 104, 10643-10648 (2007). (Pubitemid 47185718)
70. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
71. Samuel, B. S. & Gordon, J. I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl Acad. Sci. USA 103, 10011-10016 (2006). (Pubitemid 43993614)
72. Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. USA 106, 2365-2370 (2009).
73. Armougom, F., Henry, M., Vialettes, B., Raccah, D. & Raoult, D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4, e7125 (2009).
74. Kane, M. et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334, 245-249 (2011).
75. Kuss, S. K. et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249-252 (2011).
76. Chow, J., Tang, H. & Mazmanian, S. K. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr. Opin. Immunol. 23, 473-480 (2011).
77. Chow, J. & Mazmanian, S. K. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7, 265-276 (2010).
78. Xu, J. et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299, 2074-2076 (2003). (Pubitemid 36383735)
79. Hooper, L. V., Midtvedt, T. & Gordon, J. I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307 (2002). (Pubitemid 35221463)
80. Sonnenburg, J. L. et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955-1959 (2005). (Pubitemid 40404703)
81. Hooper, L. V., Stappenbeck, T. S., Hong, C. V. & Gordon, J. I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunol. 4, 269-273 (2003). (Pubitemid 36322137)
82. Kelly, D. et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nature Immunol. 5, 104-112 (2004). (Pubitemid 38081475)
83. Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915-1920 (2005). (Pubitemid 40404694)
84. Davic, R. D. Linking keystone species and functional groups: a new operational definition of the keystone species concept. Conserv. Ecol. 7, r11 (2003).
85. Simberloff, D. (ed.) Community and Ecosystem Impacts of Single-Species Extinctions (Princeton Univ. Press, 2003).
86. Honda, K. Porphyromonas gingivalis sinks teeth into the oral microbiota and periodontal disease. Cell Host Microbe 10, 423-425 (2011).